Evidence map›Paper›PMID 42881883›Full record

ArticleJournal of clinical medicine2026

Reply to Crespo, J.; Iruzubieta, P. Comment on "Orozco-Beltrán et al. Evaluation, Management and Therapeutic Approach of Cardiovascular-Kidney-Metabolic Syndrome: A Multidisciplinary Delphi Expert Consensus.

Domingo Orozco-Beltrán, Borja Quiroga, Alberto Esteban-Fernández, Ana Lorenzo Almorós, Virginia Bellido, Teresa Benedito Pérez de Inestrosa, Rubén de Haro, Xoana Taboada, Juan Carlos Romero-Vigara

Abstract readComment
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Domingo Orozco-BeltránDepartment of Clinical Medicine, School of Medicine, Miguel Hernández University, San Juan de Alicante, 03550 Elche, Spain.ORCID 0000-0002-8231-2635
Borja QuirogaService of Nephrology, University Hospital of La Princesa, 28006 Madrid, Spain.ORCID 0000-0001-5730-1929
Alberto Esteban-FernándezService of Cardiology, Severo Ochoa University Hospital, 28914 Leganés, Spain.ORCID 0000-0002-3839-7336
Ana Lorenzo AlmorósService of Internal Medicine, Gregorio Marañón General University Hospital, Complutense University of Madrid, 28007 Madrid, Spain.
Virginia BellidoClinical Management Unit of Endocrinology and Nutrition, Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocío University Hospital, CSIC, University of Sevilla, 41013 Sevilla, Spain.ORCID 0000-0002-8384-043X
Teresa Benedito Pérez de InestrosaMédico de Familia, Servicio Andaluz de Salud, 18013 Granada, Spain.
Rubén de HaroMedical Affairs Department, Boehringer Ingelheim, 08174 Sant Cugat del Vallés, Spain.
Xoana TaboadaMedical Department, Eli Lilly and Company, 28108 Alcobendas, Spain.ORCID 0009-0003-5777-9107
Juan Carlos Romero-VigaraHealth Service of Aragon, 50017 Zaragoza, Spain.ORCID 0009-0002-4944-8319

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We would like to thank Crespo and Iruzubieta for their thoughtful and constructive comment [...].

Identifiers

PMID42881883
PMCPMC13665531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.